New perspectives in ovarian cancer treatment

Simple item page
dc.contributor.authorSchmid, B.C.
dc.contributor.authorOehler, M.K.
dc.date.issued2014
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityBernd C. Schmid, Martin K. Oehler
dc.identifier.citationMaturitas, 2014; 77(2):128-136
dc.identifier.doi10.1016/j.maturitas.2013.11.009
dc.identifier.issn0378-5122
dc.identifier.issn1873-4111
dc.identifier.orcidOehler, M.K. [0000-0002-2651-5913]
dc.identifier.urihttp://hdl.handle.net/2440/91153
dc.language.isoen
dc.publisherElsevier Ireland
dc.rights© 2013 Elsevier Ireland Ltd. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.maturitas.2013.11.009
dc.subjectOvarian cancer; Targeted therapy; Anti-angiogenic therapy; PARP inhibitors; Immunotherapy; Intraperitoneal chemotherapy
dc.titleNew perspectives in ovarian cancer treatment
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Paediatrics publications